Inovio Pharmaceuticals (INO) Assets Average (2016 - 2025)
Historic Assets Average for Inovio Pharmaceuticals (INO) over the last 17 years, with Q3 2025 value amounting to $68.8 million.
- Inovio Pharmaceuticals' Assets Average fell 4285.98% to $68.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $68.8 million, marking a year-over-year decrease of 4285.98%. This contributed to the annual value of $142.1 million for FY2024, which is 4530.18% down from last year.
- According to the latest figures from Q3 2025, Inovio Pharmaceuticals' Assets Average is $68.8 million, which was down 4285.98% from $77.8 million recorded in Q2 2025.
- In the past 5 years, Inovio Pharmaceuticals' Assets Average registered a high of $623.4 million during Q2 2021, and its lowest value of $68.8 million during Q3 2025.
- Its 5-year average for Assets Average is $301.6 million, with a median of $249.8 million in 2023.
- Its Assets Average has fluctuated over the past 5 years, first soared by 14740.2% in 2021, then crashed by 5121.81% in 2024.
- Inovio Pharmaceuticals' Assets Average (Quarter) stood at $515.9 million in 2021, then dropped by 28.23% to $370.3 million in 2022, then plummeted by 50.84% to $182.0 million in 2023, then crashed by 39.5% to $110.1 million in 2024, then plummeted by 37.52% to $68.8 million in 2025.
- Its last three reported values are $68.8 million in Q3 2025, $77.8 million for Q2 2025, and $100.2 million during Q1 2025.